Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Operating Income (2020 - 2025)

Agilon Health (AGL) has disclosed Operating Income for 6 consecutive years, with -$193.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income fell 79.3% year-over-year to -$193.8 million, compared with a TTM value of -$463.2 million through Dec 2025, down 58.57%, and an annual FY2025 reading of -$463.2 million, down 58.57% over the prior year.
  • Operating Income was -$193.8 million for Q4 2025 at Agilon Health, down from -$131.3 million in the prior quarter.
  • Across five years, Operating Income topped out at $417000.0 in Q1 2023 and bottomed at -$298.4 million in Q2 2021.
  • Average Operating Income over 5 years is -$73.0 million, with a median of -$37.4 million recorded in 2021.
  • The sharpest move saw Operating Income crashed 23730.91% in 2021, then soared 156.12% in 2023.
  • Year by year, Operating Income stood at -$26.2 million in 2021, then tumbled by 106.65% to -$54.1 million in 2022, then plummeted by 195.2% to -$159.6 million in 2023, then soared by 32.27% to -$108.1 million in 2024, then tumbled by 79.3% to -$193.8 million in 2025.
  • Business Quant data shows Operating Income for AGL at -$193.8 million in Q4 2025, -$131.3 million in Q3 2025, and -$116.0 million in Q2 2025.